Rachel Ryu

651 total citations
18 papers, 438 citations indexed

About

Rachel Ryu is a scholar working on Cardiology and Cardiovascular Medicine, Pediatrics, Perinatology and Child Health and Obstetrics and Gynecology. According to data from OpenAlex, Rachel Ryu has authored 18 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 4 papers in Pediatrics, Perinatology and Child Health and 4 papers in Obstetrics and Gynecology. Recurrent topics in Rachel Ryu's work include Pregnancy and preeclampsia studies (4 papers), Heart Failure Treatment and Management (4 papers) and Cardiac Arrest and Resuscitation (3 papers). Rachel Ryu is often cited by papers focused on Pregnancy and preeclampsia studies (4 papers), Heart Failure Treatment and Management (4 papers) and Cardiac Arrest and Resuscitation (3 papers). Rachel Ryu collaborates with scholars based in United States, Israel and Canada. Rachel Ryu's co-authors include Cheryl L. Patten, Mary F. Hébert, Armin Sadighi, Fatemeh Akhlaghi, Karen Hays, Kristina E. Ward, Thomas R. Easterling, Danny D. Shen, Sara Eyal and Steve N. Caritis and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Bacteriology and Clinical Pharmacokinetics.

In The Last Decade

Rachel Ryu

18 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rachel Ryu United States 10 105 88 85 82 72 18 438
Fumihiko Ushigome Japan 13 105 1.0× 152 1.7× 325 3.8× 40 0.5× 218 3.0× 14 662
Lindsay M. Henderson United States 7 133 1.3× 137 1.6× 52 0.6× 85 1.0× 42 0.6× 15 465
Daniel Seifu Ethiopia 13 22 0.2× 52 0.6× 59 0.7× 49 0.6× 30 0.4× 32 363
Veronika Rozehnal Germany 6 58 0.6× 70 0.8× 125 1.5× 8 0.1× 74 1.0× 7 371
Martha Sosa‐Macías Mexico 18 315 3.0× 130 1.5× 126 1.5× 11 0.1× 184 2.6× 53 706
Esther Giesbrecht Canada 11 32 0.3× 46 0.5× 36 0.4× 19 0.2× 68 0.9× 14 339
Blanca Patricia Lazalde-Ramos Mexico 11 59 0.6× 76 0.9× 31 0.4× 23 0.3× 66 0.9× 28 303
H. Abul Kuwait 12 61 0.6× 52 0.6× 36 0.4× 15 0.2× 27 0.4× 27 419
Lauren Krill United States 12 26 0.2× 167 1.9× 75 0.9× 23 0.3× 14 0.2× 22 485
Beverley L. Ketel United States 12 151 1.4× 55 0.6× 133 1.6× 111 1.4× 63 0.9× 26 640

Countries citing papers authored by Rachel Ryu

Since Specialization
Citations

This map shows the geographic impact of Rachel Ryu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Ryu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Ryu more than expected).

Fields of papers citing papers by Rachel Ryu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Ryu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Ryu. The network helps show where Rachel Ryu may publish in the future.

Co-authorship network of co-authors of Rachel Ryu

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Ryu. A scholar is included among the top collaborators of Rachel Ryu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Ryu. Rachel Ryu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ryu, Rachel, et al.. (2024). Peer mentoring in pharmacy programs: Recommendations for implementation based on a review of available literature. Currents in Pharmacy Teaching and Learning. 16(6). 496–502. 2 indexed citations
2.
Ryu, Rachel, et al.. (2023). Renal function estimating equations performance during pregnancy and postpartum. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 43(5). 359–371. 3 indexed citations
3.
Ryu, Rachel, et al.. (2022). The Usage of Concomitant Beta-Blockers with Vasopressors and Inotropes in Cardiogenic Shock. SHILAP Revista de lepidopterología. 10(4). 64–64. 2 indexed citations
4.
Ryu, Rachel, et al.. (2022). DOACs in Mechanical and Bioprosthetic Heart Valves: A Narrative Review of Emerging Data and Future Directions. Clinical and Applied Thrombosis/Hemostasis. 28. 2985285082–2985285082. 16 indexed citations
5.
Nandkeolyar, Shuktika, et al.. (2021). A Review of Inotropes and Inopressors for Effective Utilization in Patients With Acute Decompensated Heart Failure. Journal of Cardiovascular Pharmacology. 78(3). 336–345. 4 indexed citations
6.
Ryu, Rachel, et al.. (2021). Critical Analysis of Apixaban Dose Adjustment Criteria. Clinical and Applied Thrombosis/Hemostasis. 27. 2975202662–2975202662. 3 indexed citations
7.
Nandkeolyar, Shuktika, Gary E. Fraser, Rachel Ryu, et al.. (2021). Predictors of In-hospital Mortality in Cardiogenic Shock Patients on Vasoactive or Inotropic Support. Clinical Medicine Insights Cardiology. 15. 1957549033–1957549033. 9 indexed citations
8.
Ryu, Rachel, et al.. (2020). Association of Sacubitril/Valsartan with Metabolic Parameters in Patients with Reduced Ejection Fraction Heart Failure at a Multidisciplinary Clinic. Metabolic Syndrome and Related Disorders. 19(2). 115–118. 2 indexed citations
10.
Ryu, Rachel, Thomas R. Easterling, Brian Phillips, et al.. (2019). Effect of N‐Acetyltransferase 2 Genotype on the Pharmacokinetics of Hydralazine During Pregnancy. The Journal of Clinical Pharmacology. 59(12). 1678–1689. 18 indexed citations
11.
Ryu, Rachel & Kristina E. Ward. (2018). Atezolizumab for the First-Line Treatment of Non-small Cell Lung Cancer (NSCLC): Current Status and Future Prospects. Frontiers in Oncology. 8. 277–277. 23 indexed citations
12.
Ryu, Rachel, Thomas R. Easterling, Steve N. Caritis, et al.. (2018). Prednisone Pharmacokinetics During Pregnancy and Lactation. The Journal of Clinical Pharmacology. 58(9). 1223–1232. 36 indexed citations
13.
Sadighi, Armin, et al.. (2018). Contribution of cytochrome P450 and other enzymes to the metabolism of FDA approved drugs between 2005–2016. Drug Metabolism and Pharmacokinetics. 33(1). S36–S36. 1 indexed citations
14.
Ryu, Rachel, Sara Eyal, Thomas R. Easterling, et al.. (2015). Pharmacokinetics of metoprolol during pregnancy and lactation. The Journal of Clinical Pharmacology. 56(5). 581–589. 50 indexed citations
15.
Ryu, Rachel, Sara Eyal, Henry G. Kaplan, et al.. (2014). Pharmacokinetics of doxorubicin in pregnant women. Cancer Chemotherapy and Pharmacology. 73(4). 789–797. 28 indexed citations
16.
Ryu, Rachel, Karen Hays, & Mary F. Hébert. (2014). Gestational diabetes mellitus management with oral hypoglycemic agents. Seminars in Perinatology. 38(8). 508–515. 40 indexed citations
17.
Hays, Karen, Rachel Ryu, Elizabeth M. Swisher, et al.. (2013). Duration of Cisplatin Excretion in Breast Milk. Journal of Human Lactation. 29(4). 469–472. 10 indexed citations
18.
Ryu, Rachel & Cheryl L. Patten. (2008). Aromatic Amino Acid-Dependent Expression of Indole-3-Pyruvate Decarboxylase Is Regulated by TyrR inEnterobacter cloacaeUW5. Journal of Bacteriology. 190(21). 7200–7208. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026